Newsletter | June 20, 2025

06.20.25 -- How Life Science Angel Investors Evaluate Biotech Startups

FEATURED ARTICLE

Biotech Angel Investing With Yaniv Sneor

On this week's Business of Biotech episode, Yaniv Sneor, founder of the Mid Atlantic Bio Angels and CEO at Native State Therapeutics, explains how life science angel investors evaluate biotech startups, and offers tips for young drug developers in search of funding. The conversation covers how to create a successful pitch, red flags for potential investors, the importance of angel investing syndicates, the sweet spots for exit timelines and funding amounts, and why it still makes sense to invest in biotech over other industry sectors.

INDUSTRY INSIGHTS

Accelerating Clinical Data Review With Traceable Workflows

Discover how streamlined workflows and enhanced collaboration between data managers and medical reviewers can boost clinical trial efficiency, improve data quality, and ensure patient safety.

It's Time To Use It Europe's Platform For Driving More Flexible Clinical Trials

Despite recent setbacks, Europe possesses inherent strengths in clinical research, and a concerted effort is needed to transform its potential into a thriving and competitive environment.

Customized Release Through Dispersed Dosage Formats

Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.

What Is Direct-To-Patient Clinical Trial Recruitment?

What is the direct-to-patient (DtP) recruitment and how can sponsors and organizers leverage this approach to boost patient recruitment and achieve clinical trial goals.

Rare Disease R&D: Continued Growth Amid Challenges

The market for rare disease treatments continues to grow but it is not without its challenges, including small patient populations and a lack of existing research.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable?  Read these guidelines first before submitting your idea or your article to our editorial director.